Your browser doesn't support javascript.
loading
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.
Horwitz, M E; Chute, J P; Gasparetto, C; Long, G D; McDonald, C; Morris, A; Rizzieri, D A; Sullivan, K M; Chao, N J.
Affiliation
  • Horwitz ME; Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. mitchell.horwitz@duke.edu
Bone Marrow Transplant ; 47(8): 1051-5, 2012 Aug.
Article in En | MEDLINE | ID: mdl-22080963
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Anti-HIV Agents / Hematopoietic Stem Cell Mobilization / Heterocyclic Compounds Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Anti-HIV Agents / Hematopoietic Stem Cell Mobilization / Heterocyclic Compounds Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article Affiliation country: